OOIR: Observatory of International Research

Papers

(The H4-Index of Thrombosis Research is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Linezolid impair proplatelet formation by reducing mitochondrial energy metabolism in MEG-01 cells	49
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	42
Distinct Immunologic Mediators Are Associated with Venous Thromboembolism in Multiply Injured Patients	39
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	38
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	37
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	36
Editorial Board	36
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	33
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis	33
DOACs: A perfect fit for patients with bariatric surgery?	32
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study	32
A novel role of acellular hemoglobin in hemolytic thrombosis	31
Thrombosis after surgical splenectomy – why, in whom and can we prevent it?	30
Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review	28
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	28
Treatment strategies, bleeding, long-term recurrence and mortality in abdominal vein thrombosis: Findings from the TROLL registry	27
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	27
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	27
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	27
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	27
Regulation of fibrinogen synthesis	26
Impact of aetiology and liver stiffness on thrombin generation in compensated cirrhosis	25
LY96–CCNT1–IFI44L core molecular features characterize VTE-associated inflammatory prothrombotic risk in elderly cancer patients	25
The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum	25
Prevalence and clinical outcomes associated with proximal deep vein thrombosis at hospital admission detected by bedside ultrasound in patients hospitalized in a medical oncology ward: An exploratory	25